Clene CEO granted 65,000 stock options

Clene Inc. reported that President and CEO Robert Dee Etherington received a grant of stock options covering 65,000 shares of common stock.

Rhea-AI Filing Summary

Clene Inc. reported that President and CEO Robert Dee Etherington received a grant of stock options covering 65,000 shares of common stock. The options have an exercise price of $5.53 per share and expire on June 10, 2036. According to the grant terms, 25% of the options vest on June 11, 2027, with the remaining shares vesting in 36 equal monthly installments starting on July 11, 2027 until fully vested. This is a compensation-related award rather than an open-market purchase or sale.

Insider Trade Summary

Grant/Award: 65,000 shares

Grant/Award 1 txn

Insider Etherington Robert Dee

Role President & CEO

Type	Security	Shares	Price	Value
Grant/Award	stock option	65,000	$0.00	$0.00

Holdings After Transaction: stock option — 65,000 contracts (Direct)

Footnotes (1)

1. F1. This option was granted on June 11, 2026 as an option for 65,000 shares of Common Stock under the Clene Inc Amended 2020 Stock Plan at an exercise price of $5.53 per share. The options vest with respect to the first 25% of such shares on June 11, 2027 and then in 36 equal installments of the balance of the shares of Common Stock on the 11th day of each month beginning July 11, 2027 until such share are fully vested.

Key Figures

Option grant size: 65,000 options Exercise price: $5.53 per share Underlying shares: 65,000 shares +3 more

6 metrics

Option grant size 65,000 options Stock option grant to CEO on June 11, 2026

Exercise price $5.53 per share Exercise price for 65,000 underlying common shares

Underlying shares 65,000 shares Common stock underlying the granted options

Vesting cliff 25% on June 11, 2027 Initial vesting of option grant

Monthly vesting period 36 installments Monthly vesting starting July 11, 2027

Option expiration June 10, 2036 Expiration date of the stock options

Key Terms

stock option, exercise price, vest, Amended 2020 Stock Plan

4 terms

stock option financial

"This option was granted on June 11, 2026 as an option for 65,000 shares"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

exercise price financial

"under the Clene Inc Amended 2020 Stock Plan at an exercise price of $5.53"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vest financial

"The options vest with respect to the first 25% of such shares on June 11, 2027"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

Amended 2020 Stock Plan financial

"under the Clene Inc Amended 2020 Stock Plan at an exercise price"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Clene (CLNN) CEO Robert Dee Etherington report on this Form 4?

Robert Dee Etherington reported receiving a grant of stock options for 65,000 shares of Clene common stock. These options are part of his compensation and do not reflect an open-market buy or sell of existing shares.

How many Clene (CLNN) shares are covered by the new stock option grant?

The new stock option grant covers 65,000 shares of Clene common stock. This gives the CEO the right, but not the obligation, to purchase those shares in the future at a fixed exercise price.

What is the exercise price of the Clene (CLNN) stock options granted to the CEO?

The stock options granted to the CEO have an exercise price of $5.53 per share. This means he can buy the 65,000 underlying shares at $5.53 regardless of the market price once the options vest.

When do the newly granted Clene (CLNN) stock options begin vesting?

The options begin vesting on June 11, 2027, when 25% of the grant vests. The remaining options then vest in 36 equal monthly installments starting July 11, 2027, until the entire 65,000-share grant is vested.

When do the Clene (CLNN) CEO’s new stock options expire?

The CEO’s newly granted stock options expire on June 10, 2036. If the options are not exercised by that date, the right to purchase the 65,000 underlying shares at $5.53 per share will lapse.

Are these Clene (CLNN) Form 4 transactions open-market buys or sells?

No, this Form 4 reports a compensation-related grant of stock options, coded as an acquisition. It is not an open-market purchase or sale of Clene shares, but rather an award under the company’s Amended 2020 Stock Plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/15/2026 - 02:23 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Etherington Robert Dee

(Last) (First) (Middle)

6550 SOUTH MILLROCK DRIVE

SUITE G50

(Street)

SALT LAKE CITY UTAH 84121

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Clene Inc. [ CLNN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
stock option	$5.53	06/11/2026		A		65,000		(1)	06/10/2036	common stock	65,000	$0	65,000	D

Explanation of Responses:

1. This option was granted on June 11, 2026 as an option for 65,000 shares of Common Stock under the Clene Inc Amended 2020 Stock Plan at an exercise price of $5.53 per share. The options vest with respect to the first 25% of such shares on June 11, 2027 and then in 36 equal installments of the balance of the shares of Common Stock on the 11th day of each month beginning July 11, 2027 until such share are fully vested.

	/s/ Jerome T. Miraglia POA	06/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)